Insmed (INSM) Tops Q1 EPS by 17c ; Offers Guidance
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $129.41 +1.67%
EPS Growth %: +78.3%
Financial Fact:
Research and development: 23.43M
Today's EPS Names:
ANAB, ANIX, MNY, More
EPS Growth %: +78.3%
Financial Fact:
Research and development: 23.43M
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q1 EPS of ($1.06), $0.17 better than the analyst estimate of ($1.23). Revenue for the quarter came in at $75.5 million versus the consensus estimate of $78.51 million.
GUIDANCE:
Insmed sees FY2024 revenue of $340-360 million, versus the consensus of $354.7 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
- Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
- Skillsoft (SKIL) Tops Q2 EPS by 14c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
